Delivery Order SPE2DB24D2216-SPE2DB25FGPND
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,919.58 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on July 24, 2025, with a completion date of July 25, 2025. This competitive award was issued under a firm fixed-price contract type with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $14,466.50 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, which is not set aside for any specific category, represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was competitively awarded and will be performed at the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,266.60 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,995.98 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the defense...
- The Defense Logistics Agency awarded a delivery order valued at $27,380.24 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml quantities. This firm fixed-price delivery order was competitively awarded without set-aside designations and carries an ultimate completion date of July 30, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $1,136.92. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a $5,768.41 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml), with performance completion required by July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,550.33 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL) with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,858.37 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). The contract utilizes firm fixed pricing and carries an ultimate completion date of August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,741.65 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's headquarters...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPNDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,250.60 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen fulfills critical medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded delivery orders encompassing specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 8/14/25 |